Shlomi Schwartzblat

Shlomi Schwartzblat is an accomplished entrepreneur and investor with extensive experience in business development and management across various sectors, including life sciences, technology, and fintech. As the CEO and Founder of Gavriel Ventures since January 2016, Shlomi leads investments and services for startups and investors in both local and international markets. In addition to this role, Shlomi serves as a Partner at LATAM Business Development Group, focusing on opportunities in the Latin American markets, particularly Brazil. Current responsibilities also include serving as VP of Strategy and Business Development at TA9 and holding various board positions and directorships at companies such as OCON Medical, Raziel Therapeutics, Xsight Systems, EYEYON MEDICAL, Bonfix, and Laryngoport. Shlomi's academic background includes an MBA from Tel Aviv University and an MSc in Engineering and Information Systems from Ben-Gurion University of the Negev.